New immune cell therapy benefits laboratory models of ALS and has some positive results in an individual with the disease Post author: Post published:July 11, 2024 Post category:News Feed Post comments:0 Comments The study provides the basis for a phase I clinical trial in additional participants. You Might Also Like Loneliness grows as we age May 1, 2024 First-of-its-kind test can predict dementia up to nine years before diagnosis June 7, 2024 Growing body of evidence links HPV with heart disease March 25, 2025 Leave a Reply Cancel replyCommentEnter your name or username to comment Enter your email address to comment Enter your website URL (optional) Save my name, email, and website in this browser for the next time I comment.